Is there any correlation between F-18 FDG PET-CT scan metabolic parameters and programmed death-ligand 1 expression in patients with metastatic non-small cell lung carcinoma?
Lokesh Kumar, Divya Shivdasani, Natasha Singh, Melvika PereiraAim
The study aimed to evaluate whether there is any correlation between metabolic parameters derived from baseline fluorine-18 fluorodeoxyglucose (F-18 FDG) PET-computed tomography (CT) and programmed death-ligand 1 (PDL-1) expression in patients with metastatic non-small cell lung carcinoma (NSCLC).
Methods
33 biopsy-proven metastatic NSCLC patients were included. On immunohistochemistry, a tumor proportion score (TPS) of ≥1% was considered PDL-1 positive, while a TPS of <1% was considered negative. Metabolic parameters of the F-18 FDG PET-CT scan were obtained by drawing a region of interest around the index lung lesion. Data were analyzed using Shapiro–Wilk test of normality, unpaired t-tests/Mann–Whitney
Results
Spearman’s correlation analysis demonstrated a moderate positive correlation (
Conclusion
The study indicates that SUVmax has the potential to be used as a noninvasive biomarker for predicting PDL-1 expression in NSCLC. No significant difference was noted in the median MTV and TLG values between the PDL-1-positive and -negative groups.